Refer to below for full details of the announcement
Notification of dividend / distribution
1 / 4
Notification of dividend / distribution
Announcement Details
Part 1 - Entity and announcement details
1.1 Name of +Entity
PROBIOTEC LIMITED
1.2
Registered Number Type
Registration Number
ABN
91075170151
1.3
ASX issuer code
PBP
The announcement is New announcement
Date of this announcement
Thursday August 27, 2020
1.6 ASX +Security Code
PBP
ASX +Security Description
ORDINARY FULLY PAID
Part 2A - All dividends/distributions basic details
2A.1 Type of dividend/distribution
Ordinary
2A.2 The Dividend/distribution:
relates to a period of twelve months
2A.3 The dividend/distribution relates to the financial reporting or payment period ending ended/ending (date)
Tuesday June 30, 2020
2A.4 +Record Date
Friday October 23, 2020
Notification of dividend / distribution
2 / 4
Notification of dividend / distribution
2A.5 Ex Date
Thursday October 22, 2020
2A.6 Payment Date
Friday October 30, 2020
2A.7 Are any of the below approvals required for the dividend/distribution before business day 0 of the timetable?
Security holder approval
Court approval
Lodgement of court order with +ASIC
ACCC approval
FIRB approval
Another approval/condition external to the entity required before business day 0 of the timetable for the dividend/distribution.
No
2A.8 Currency in which the dividend/distribution is made ("primary currency")
AUD - Australian Dollar
2A.9 Total dividend/distribution payment amount per +security (in primary currency) for all dividends/distributions notified in this form
AUD 0.03000000
2A.10 Does the entity have arrangements relating to the currency in which the dividend/distribution is paid to securityholders that it wishes to disclose to the market? No
2A.11 Does the entity have a securities plan for dividends/distributions on this +security?
We have a Dividend/Distribution Reinvestment Plan (DRP)
2A.11a If the +entity has a DRP, is the DRP applicable to this dividend/distribution?
No
2A.12 Does the +entity have tax component information apart from franking?
No
Part 3A - Ordinary dividend/distribution
3A.1 Is the ordinary dividend/distribution estimated at this time?
No
3A.1b Ordinary Dividend/distribution amount per security
AUD 0.03000000
3A.1a Ordinary dividend/distribution estimated amount per +security
AUD
Notification of dividend / distribution
3 / 4
Notification of dividend / distribution
3A.2
Is the ordinary dividend/distribution franked?
3A.2a Is the ordinary dividend/distribution fully franked?
Yes
Yes
3A.3
Percentage of ordinary dividend/distribution that is
3A.3a Applicable corporate tax rate for franking credit
franked
(%)
100.0000 %
30.0000 %
3A.4 Ordinary dividend/distribution franked amount per +security
AUD 0.03000000
3A.6 Ordinary dividend/distribution unfranked amount per +security excluding conduit foreign income amount
AUD 0.00000000
3A.7 Ordinary dividend/distribution conduit foreign income amount per security
AUD 0.00000000
3A.5 Percentage amount of dividend which is unfranked
0.0000 %
Part 5 - Further information
Please provide any further information applicable to this dividend/distribution
Additional information for inclusion in the Announcement Summary
Notification of dividend / distribution
4 / 4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Probiotec Limited published this content on 26 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 August 2020 23:36:05 UTC
Probiotec Limited is an Australia-based manufacturer, packer and distributor of a range of prescription and over the counter (OTC) pharmaceuticals, complementary medicines, consumer health products, and fast-moving consumer goods (FMCG). The Company owns approximately six manufacturing facilities in Australia and distributes its products both domestically and internationally. It offers full-service contract manufacturing and packing. The Company manufactures products on behalf of a range of clients, including international pharmaceutical companies. The Company services blue-chip manufacturers, multinational FMCG companies, local manufacturers and brand custodians. All types of FMCG products are packed or handled, such as canned food, alcohol, tea and coffee, dairy and frozen foods, sauces and condiments, and bottled water. Its subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Multipack-LJM Pty Ltd, LJM (NSW) Pty Ltd and HH Packaging Pty Ltd.